FDAnews Drug Daily Bulletin

COBRA BIOMANUFACTURING SIGNS MANUFACTURING AGREEMENT

May 10, 2006
A A

Cobra Biomanufacturing Plc has announced its agreement with the International AIDS Vaccine Initiative (IAVI) and GlaxoSmithKline Biologicals S.A. (GSK Biologicals), for process development and manufacturing of two HIV vaccine candidates for evaluation in clinical trials. The program is in support of a previously announced collaboration between IAVI and GSK.
Pharmaceutical Processing